Spruce Biosciences, Inc.
SPRB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001683553
No open-market purchases or sales by Spruce Biosciences, Inc. insiders were filed in the last 90 days; 65 institutions reported holding it in 13F filings for Q2 2026, worth $116.3M in total; no superinvestor holds it.
Q1 2022 vs. Q4 2021
How the institutions holding Spruce Biosciences, Inc. changed between Q4 2021 and Q1 2022.
All holders in Q1 2022All holders in Q4 2021
| Measure | Q4 2021 | Q1 2022 | Change |
|---|---|---|---|
| Holders | 50 | 43 | −7 |
| Shares | 17.7M | 17.1M | −619.8K (−3.5%) |
| Value | $79.0M | $34.4M | −$44.6M (−56.5%) |
New holders (4)
Institutions that held Spruce Biosciences, Inc. at the end of Q1 2022 but not at the end of Q4 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Barclays PLC | 12,691 | $25.0K | 0.00% |
| Point72 Hong Kong Ltd | 2,881 | $6.00K | 0.00% |
| Amalgamated Bank | 1,084 | $2.00K | 0.00% |
| Amalgamated Financial Corp. | 1,084 | $2.00K | 0.00% |
Sold out (11)
Institutions that held Spruce Biosciences, Inc. at the end of Q4 2021 and filed for Q1 2022 without it.
| Institution | Shares, Q4 2021 | Value, Q4 2021 |
|---|---|---|
| Acadian Asset Management LLC | 71,756 | $318.0K |
| Jane Street Group, LLC | 35,953 | $160.0K |
| Bank of Montreal | 26,259 | $132.0K |
| Two Sigma Securities, LLC | 28,691 | $128.0K |
| Susquehanna International Group, LLP | 27,306 | $122.0K |
| Prelude Capital Management, LLC | 16,718 | $75.0K |
| Squarepoint Ops LLC | 13,593 | $61.0K |
| Laurion Capital Management LP | 11,337 | $51.0K |
| Captrust Financial Advisors | 1,477 | $7.00K |
| Capital Advisors, Ltd. LLC | 242 | $1.00K |
| Ellevest, Inc. | 114 | $1.00K |